A neurologist who has examined and treated a patient suffering from intractable epilepsy may provide but has no duty to provide a written recommendation for the patient’s medical use of cannabidiol to treat or alleviate symptoms of intractable epilepsy if no other satisfactory alternative treatment options exist for the patient and all of the following conditions apply:

1. 1. The patient is a permanent resident of this state.
2. 2. A neurologist has treated the patient for intractable epilepsy for at least six months. For purposes of this treatment period, and notwithstanding section 124D.2, subsection 4, treatment provided by a neurologist may include treatment by an out-of-state licensed neurologist in good standing.
3. 3. The neurologist has tried alternative treatment options that have not alleviated the patient’s symptoms.
4. 4. The neurologist determines the risks of recommending the medical use of cannabidiol are reasonable in light of the potential benefit for the patient.
5. 5. The neurologist maintains a patient treatment plan.

For future repeal of this section effective July 1, 2017, see §124D.8

2014 Acts, ch 1125, §4

Referred to in §124D.4